The activities required, both proactive and reactive, to minimize the danger and impact of acute public health events that endanger people's health across geographical regions and international boundaries
Global Health Security
Proactive
Reactive
Minimize danger and impact
Consequences of Global Health insecurity (aka 'fallout' from COVID-19 pandemic)
Diseases and Death
Economic Losses
Social instability-insecurity
Trade and Travel disrupted
Health and Public health resources strained
Families and Communities
Categories for the Global Health Agenda
Prevention
Detection
Response
Number of targets to assess the Global Health Agenda categories
Before COVID – USA ranked #1 in World for Preparedness, but COVID-19 has exposed room for improvement
Evolving challenges and complications of Health Security
Population growth
Rapid unplanned urbanization
Antibiotics misused
Globalized world
Trust or lack of trust
Vector for transmitting malaria to humans
Anopheles mosquitos are carriers can't transmit person to person
Most deadly species of plasmodium
Plasmodium falciparum
Where is Plasmodium falciparum most common
"Best Practices" for reducing malaria
Prevent Bites and resistance: standing water, protective clothing, bed nets, repellents
Treat people: preventing transmission to another person
Developing hopes for possibly eliminating malaria globally
Genetically modified mosquitos
Malaria Vaccine
AMR-TB
Anti-Microbial Resistance – Resistant to first line drug
MDR-TB
Multi-drug resistant- resistant to several first line drugs
XDR-TB
Extremely Drug Resistant – Resistant to most or all of the available drugs
Co-morbidity in the 1980's that facilitated a re-emergence of TB in wealthy countries
What causes antibiotic resistance, and why is TB so commonly resistant
Endemic
Common constant, relatively low spread; i.e flu, malaria
Epidemic
A localized sudden increase; i.e Ebola in West Africa 2014 15; aka 'outbreaks'
Pandemic
Sudden multinational-global increase of any infection; i.e COVID-19
Novel (Emerging)
A new emergent strain not previously identified, with little to public no immunity; i.e COVID-19
In September 2021, how 'deadly' was COVID-19 in the USA